drugset / Trial / NCT06612970
A Study to Evaluate Single-dose of HB0056 in Healthy Adult Participants
RandomizedSequentialQuadruple-blindOther
Summary
The aim of this study is to investigate the safety and tolerability of HB0056 in healthy subjects following single-dose.
Timeline
- Start
- 2024-11-18
- Primary completion
- 2025-06-13
- Completion
- 2025-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | HB0056 | Monoclonal antibody | — | — |
Indications
No indication recorded.